Pharmaceuticals, namely, pharmaceutical preparations to treat neurodegenerative diseases; pharmaceuticals, namely, pharmaceutical preparations to attenuate the accumulation of dysfunctional proteins

'accumul':16 'attenu':14 'diseas':8 'dysfunct':18 'name':2,10 'neurodegen':7 'pharmaceut':1,3,9,11 'prepar':4,12 'protein':19 'treat':6

Pharmaceutical research and development services; scientific research in the nature of conducting clinical trials in the field of neurodegenerative diseases; scientific research in the nature of conducting clinical trials in the field of dysfunctional protein accumulation; research and development in the field of biotechnology; research and development in the field of biochemistry; information, advisory and consultancy services in relation to all of the foregoing

'accumul':36 'advisori':54 'biochemistri':52 'biotechnolog':44 'clinic':13,28 'conduct':12,27 'consult':56 'develop':4,39,47 'diseas':20 'dysfunct':34 'field':17,32,42,50 'forego':64 'inform':53 'natur':10,25 'neurodegen':19 'pharmaceut':1 'protein':35 'relat':59 'research':2,7,22,37,45 'scientif':6,21 'servic':5,57 'trial':14,29

AMYRIAD THERAPEUTICS

Owner

Goods & Services